Navigation Links
Will new methods that increase blood flow to bone implants improve viability of engineered bone tissue?
Date:10/25/2012

New Rochelle, NY, October 22, 2012New, advanced techniques are needed that can mimic the normal blood supply that feeds natural bone to improve the viability and success of restorative procedures to replace damaged or diseased bone tissue using engineered constructs. A comprehensive review article describing the most promising strategies for vascularization of bone tissue substitutes is published in Tissue Engineering, Part B: Reviews, a peer-reviewed journal from Mary Ann Liebert, Inc. The article is available free online on the Tissue Engineering website.

The lack of an adequate blood supply to engineered bone implants has been a major limiting factor in the ability of these large tissue engineered implants to survive and integrate in the body. Many new strategies for stimulating the growth of new blood vessels and the formation of a vascular network to carry nutrients and oxygen and aid in healing are in development, as presented by Lonnissa H. Nguyen, PhD, and coauthors from Massachusetts Institute of Technology (Cambridge); Brigham and Women's Hospital, Harvard University, and Harvard Medical School (MA); Ecole Polytechnique (Palaiseau, France); Chonnam National University (Gwangju, South Korea); Stanford University (CA); Tohoku University (Sendai, Japan). They describe the different methods and their limitations in the article "Vascularized Bone Tissue Engineering: Approaches for Potential Improvement."

"There is a critical need to develop innovative techniques for tissue vascularization, and the work by Nguyen et al. demonstrates both past successes in the field and future avenues for investigation," says Reviews Co-Editor-in-Chief John P. Fisher, PhD, Professor and Associate Chair, Fischell Department of Bioengineering, University of Maryland, College Park, MD.


'/>"/>

Contact: Cathia Falvey
cfalvey@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert

Related biology technology :

1. Lifeline Biotechnologies Receives Patent for Methods to Collect and Analyze Breast Thermal Data to Determine Suspect Conditions
2. Published Findings In Human Gene Therapy Methods Journal Demonstrate Cardiums New Catheter-Based Method Significantly Boosts Gene Delivery To The Heart
3. X-BODY BioSciences to Present Novel Methods of Selecting for Antibodies Against Targets on Live Cells at CHIs Protein Engineering Summit
4. Cepheid Receives Grant to Develop Sample Processing and Amplification Methods for Detection of Bloodstream Bacteria
5. NIH media availability: Protein linked to increased risk of heart failure and death in older adults
6. Increased productivity, not less energy use, results from more efficient lighting
7. Increase in Genomic Replikin Counts Predicted Recent Avian Flu (H5N1) Outbreak in Cambodia
8. iDiverse Discovers Yeast Gene that Increases Fuel Ethanol Production Yield
9. Solar nanowire array may increase percentage of suns frequencies available for energy conversion
10. Trade Show Display Company GLM Displays Increase Sales with New E-commerce Website
11. ResearchMoz: Bone Metabolism Therapeutics Market to 2018 - Hyperparathyroidism Sector to Decline in the Absence of New Product Launches and Increased Generic Erosion for Zemplar, Hectorol and Sensipar- Market Research Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Soligenix, Inc. (OTCQB: ... company focused on developing and commercializing products to ... medical need, announced today the long-term follow-up data ... (dusquetide), a first-in-class Innate Defense Regulator (IDR), in ... and neck cancer patients undergoing chemoradiation therapy (CRT).  ...
(Date:12/8/2016)... Dec. 8, 2016  HedgePath Pharmaceuticals, Inc. (OTCQX: ... develops and plans to commercialize innovative therapeutics for ... common stock were approved for trading on the ... on the OTCQX, effective today, under the ticker ... OTCQX market, companies must meet high financial standards, ...
(Date:12/8/2016)... , Dec. 8, 2016 Eutilex Co. ... billion KRW (US $18.9M) Series A financing. This financing ... G.N. Tech Venture and SNU Bio Angel. This new ... 30.5 billion KRW (US $27.7M) since its founding in ... to bolster the development and commercialization of its immuno-oncology ...
(Date:12/8/2016)... 8, 2016   Biocept, Inc . (NASDAQ: ... of clinically actionable liquid biopsy tests to improve ... data featuring its Target Selectorâ„¢ Circulating Tumor Cell ... the detection of actionable biomarkers in patients with ... by Sara Cannon Research Institute (SCRI), the research ...
Breaking Biology Technology:
(Date:12/2/2016)... December 1, 2016 The ... Voice), Future Technology (Iris Recognition System), Vehicle Type ... Global Forecast to 2021", published by MarketsandMarkets, the ... in 2016, and is projected to grow to ... of 14.06%.      (Logo: http://photos.prnewswire.com/prnh/20160303/792302) ...
(Date:11/29/2016)... 2016   Neurotechnology , a provider ... technologies, today released FingerCell 3.0, a software ... that run on low-power, low-memory microcontrollers. FingerCell ... than 128KB of memory, enabling it to ... limited on-board resources, such as: mobile phones, ...
(Date:11/22/2016)... , Nov. 22, 2016   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... LiveWire Healthcare and Life Sciences Awards as "Most ... off an unprecedented year of recognition and growth for ... over 15 years. iMedNet ™ ...
Breaking Biology News(10 mins):